Send feedback

KIT p.Ile690Val

c.2068A>G · rs924104591 · VCV458903

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.1051 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00153%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
gastrointestinal stromal tumor

Computational evidence

Protein change
AlphaMissense0.1051likely benign
REVEL0.271benign-leaning
SaProtLLR -6.75tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2all four deltas below 0.2 · A>T here scores Δ0.37 · evaluated, not missing
Constraint at this position
ConservationphyloP 9.4GERP 2.6, phastCons 1
Regional constrainto/e 0.72unconstrained · MANE · 4,114 bp · p 4.1e-05 · regional, not allelic
Overall
CADD21.5PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00153% European (non-Finnish) · 18/1,179,796 alleles
Filtering AF 0.000953% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000787%
Overall 0.00118% 19/1,613,644 alleles · very rare exomes 18/1,461,486 · genomes 1/152,158 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,462
European (non-Finnish)grpmax 0.00153% 65,544

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
KIT
Protein
p.Ile690Val
Coding
c.2068A>G
MANE Select
NM_000222
dbSNP
rs924104591
Type
single nucleotide variant
Location
chr4:54729412 (GRCh38)
Gene constraint
LOEUF 0.24 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 78.52 · 65 PDB
Residue 690
the protein kinase domain
Full KIT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

gastrointestinal stromal tumor — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary neoplastic syndrome

For Gastrointestinal stromal tumor (Orphanet):

Inheritance
Autosomal dominant, Not applicable
Onset
Adolescent, Adult, Childhood
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kit-p-ile690val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown